Enhanced Group Reports Nearly $62 Million Q2 Loss After Enhanced Games

Summary

Enhanced Group’s Q2 report, covered by TechCrunch on August 20, 2026, showed a net loss of nearly $62 million, much of it from staging May’s Las Vegas Enhanced Games, where athletes could use performance-enhancing drugs normally banned in professional sports. Backed by Peter Thiel and staffed by crypto, AI and biotech veterans, the event produced only one world record, in swimming, where records fall often, despite promises to transform organized sports. Founded in 2023, Enhanced Group completed a 2026 IPO at a $1.2 billion valuation and generated $17.7 million in Q2, mostly from Games sponsorships rather than its core digital telehealth business. Disclosure on that business was scant, although it sells personalized, FDA-approved peptides, testosterone injections, GLP-1 weight-loss drugs and similar treatments.

The loss clouds executives’ claim that the Games will recur annually. Enhanced is promoting Enhanced Breakers, an online series it says costs a fraction of a full event while maintaining athlete competition, audiences, sponsorship and year-round visibility for performance medicine. The wider peptide market is expanding after the Trump administration’s Food and Drug Administration reclassified several substances long in a legal gray area, though further review is required before broader sales. The FDA’s parent, the U.S. Department of Health and Human Services, is led by Robert F. Kennedy Jr., whose health views have been called dangerous by professionals inside and outside government. Silicon Valley startups Superpower and Noho Labs are exploiting demand for biohacking and fashionable supplements as growth outpaces state regulatory systems.